Delicourt A, Touzin K, Lavoie A, Therrien R, Lebel D. [Monitoring of vancomycin in pediatrics].
Med Mal Infect 2012;
42:167-70. [PMID:
22424794 DOI:
10.1016/j.medmal.2012.02.001]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2011] [Revised: 01/23/2012] [Accepted: 02/03/2012] [Indexed: 12/11/2022]
Abstract
OBJECTIVES
The authors wanted to determine if the current local practice (initial prescription and monitoring) in pediatrics allowed reaching vancomycin therapeutic concentrations.
PATIENTS AND METHODS
Thirty patients that had received vancomycin for at least five days with at least one evaluation of serum concentration, at the Sainte-Justine university hospital center, were retrospectively studied. Vancomycin trough and peak levels were analyzed.
RESULTS
The values of vancomycin serum concentration were within therapeutic ranges (local standards of 5 to 10mg/L for trough level and 20 to 40 mg/L for peak level) in 60% and 33% of cases at the fifth day of treatment for trough and peak levels, respectively.
CONCLUSION
The current practice does not allow reaching vancomycin serum concentrations in the target range. Using a wider range for the trough values could be considered.
Collapse